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  E
ver since Haldane proposed in 
1949 that thalassaemia might 
protect individuals against the 
scourge of malaria [1], the challenge 
has been to provide supporting 
evidence—be it at the cellular, clinical, 
or epidemiological level. The general 
topic of human red cell polymorphisms 
and malarial protection has attracted 
enormous interest, largely because this 
subject provides the most compelling 
example of natural selection and, 
hence, “survival of the ﬁ  ttest” in 
humans. Sickle cell trait remains the 
paradigm of a red cell polymorphism 
that protects against malaria. Several 
lines of evidence, including plausible 
cellular mechanisms, conﬁ  rm that this 
haemoglobinopathy provides up to 
90% protection against death due to 
malaria [2]. However, there are many 
gaps in our knowledge of whether 
other common red cell variants, 
notably thalassaemia, might protect 
against malaria and of the mechanism 
of such protection. 
  Interactions  between 
Thalassaemias and Malaria
    Why has investigation of the interaction 
between thalassaemias and malaria 
remained inconclusive despite our best 
efforts? For β-thalassaemia, it is only 
in a limited part of West Africa that 
it continues to co-exist with malaria. 
Malaria has been eradicated from most 
other regions where β-thalassaemia 
is common. The ﬁ  ndings of Willcox 
et al. support a protective role for β-
thalassaemia, in which heterozygotes 
one-to-four years old appear to have 
a reduced risk of malaria, using an 
arbitrary density criterion of 1 × 
109/l relative to controls (relative 
risk, 0.45; upper 95% conﬁ  dence 
interval, 0.79) [3]. By contrast, α+-
thalassaemia (in which one or two of 
the four α-globin genes are deleted) 
is exceedingly common throughout 
sub-Saharan Africa, an area of high 
malarial transmission. However, thus 
far, the effects of α+-thalassaemia on 
the clinical manifestations of malaria 
in this area have not been extensively 
studied. And the few studies that have 
been carried out on the relationship 
between α+-thalassaemia and malaria 
have not provided an all-encompassing 
and plausible cellular mechanism for 
protection. 
    Malarial parasites can certainly 
invade and multiply within α+-
thalassaemic cells [4]. They also 
appear to cytoadhere equally well 
to endothelial cells as do parasitized 
normal red cells [5]. So how does 
thalassaemia protect against malaria? 
Carlson and colleagues proposed 
(with supporting evidence) that 
thalassaemic cells have a reduced ability 
to form rosettes (a process in which 
uninfected red cells bind to infected 
cells), which causes harm perhaps by 
aiding and abetting the obstruction 
of capillary blood ﬂ  ow and leading to 
sequestration of schizont-infected red 
cells in vital organs [6]. Thalassaemic 
red cells also appear to bind increased 
amounts of immunoglobulin, which 
might favour early removal of those 
red cells containing parasites [7]; 
perhaps, they bind less complement, 
sparing those cells with reduced 
complement [8]. We just do not know 
why thalassaemia protects against 
malaria, leaving our current knowledge 
in a state of conjecture. While study of 
the association of disease with genetic 
polymorphisms may be intellectually 
attractive, some would argue that it is of 
little clinical relevance. 
    A New Study on α+-Thalassaemia
    Notwithstanding this, Sammy Wambua, 
Thomas Williams, and colleagues, 
[9] in a new study in   PLoS Medicine  , 
have now cogently approached 
the conundrum of α+-thalassaemia 
and malaria in a structured and 
compelling fashion within an area 
of intensive malarial transmission 
in sub-Saharan Africa. They studied 
two cohorts of children: (1) a cohort 
with “mild disease”, recruited from 
an age-stratiﬁ  ed population sample, 
which was monitored using weekly 
clinical surveillance for three years; 
and (2) a “birth cohort” of children 
born between 1992 and 1995 within 
a deﬁ  ned geographical area of the 
Kenyan coast in East Africa, whose 
admissions to hospital were recorded. 
Slide-positive parasitaemia (with or 
without symptoms), as well as parasite 
density, was clearly deﬁ  ned. Moreover, 
deﬁ  nitions of severe malaria—largely, 
coma, more than two seizures in 24 
hours, parasitaemia greater than 
20%, and severe malarial anaemia 
(haemoglobin concentration less than 
50 g/l)—were carefully delineated. 
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    In brief, the authors found that 
α+-thalassaemia did not protect 
against parasitisation in asymptomatic 
individuals. Furthermore, α+-
thalassaemia did not protect against 
symptomatic malaria, nor did it lead to 
a reduction in the density of parasites 
in peripheral blood. In the birth 
cohort, there was reduced admission 
to hospital of α+-thalassaemic children 
with malaria or severe malaria. 
An even more tantalizing ﬁ  nding 
was that thalassaemia provided no 
protection against cerebral malaria 
unless accompanied by anaemia—the 
protection by α+-thalassaemia appeared 
to be mainly conﬁ  ned to severe 
anaemia. α+-thalassaemia also appeared 
to protect against nonmalarial anaemia. 
    The researchers also investigated 
other major nonmalarial diagnoses—
such as upper and lower respiratory 
tract infections, gastroenteritis, and 
skin or helminthic infections—and 
found that the occurrence of lower 
respiratory tract infections in the 
mild disease cohort was lower 
in those with α+-thalassaemia. 
Protection by α+-thalassaemia against 
nonmalarial disease—including 
respiratory infection, gastroenteritis, 
and meningitis—has previously 
been documented [10]. Perhaps 
most interesting was that although 
average haemoglobin concentrations 
were lower in the children with α+-
thalassaemia, both in steady state 
and during mild malarial attacks, this 
result was reversed in severe disease 
when the children with thalassaemia 
had relatively higher haemoglobin 
concentrations. 
    Could thalassaemia, in reality, 
protect against nonmalarial anaemia 
as found in this study? The absence 
of malaria parasites in the blood of 
an individual with severe anaemia 
living in a highly endemic area for 
malaria might not be sufﬁ  cient to 
exclude a diagnosis of malaria. Malarial 
infection leaves a wake of red cell 
destruction, which often continues 
long after parasites have disappeared 
or are microscopically undetectable. 
The question of whether thalassaemia 
protects against nonmalarial anaemia 
can only be addressed in a study 
carried out in a nonmalarious area 
where thalassaemia and equivalent 
socioeconomic deprivation occur. Such 
an area would be hard to ﬁ  nd: the 
coexistence of deprivation and malaria 
go almost hand in hand [11]. 
  Conclusion
    This extensive and well-executed 
study concludes that α+-thalassaemia 
does not protect individuals against 
acquiring malarial infection, 
becoming symptomatic, or developing 
high parasite densities. However, the 
study also concludes that the risks of 
developing severe malaria, especially 
malarial anaemia, are reduced in 
people with α+-thalassaemia (the 
implication is that people with α+-
thalassaemia also have reduced risk of 
malaria-speciﬁ  c mortality, although 
the authors did not show this). How 
those with thalassaemia appear to be 
protected against developing severe 
anaemia with or without malaria and 
why they might be protected against 
lower respiratory tract infections 
remain unexplained. Perhaps answers 
to these questions might turn out to 
be more rewarding than they ﬁ  rst 
appear.   
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